1Chesnut CH 3rd,Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon ealcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. Am J Med, 2000,109(4) :267.
2Harris ST, Watts NB, Jackson RD, et al. Four- year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. Am J Med, 1993,95(6) :557.
3Dawson - Hughes B, Harris SS, Krall EA, et al. Effect of calcium and Vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Medl,1997,337(10):670.
4Delmas PD, Bjarnason NH, Mitlak BH, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations,and uterine endometrium in postmenopausal women. N Engl J Med, 1997,337(23) :1641.
5Walsh BW,Kuller LH, Wild RA, et al. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA, 1998,279(18) :1445.
6Overgaard KY, Hansen MA, Jensen SB, et al. Effect of calcitonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose - response study. BMJ, 1992, 305(6853): 556.
7Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone( 1 -34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med, 2001, 344(19): 1434.
8Tilyard MW,Spears GF,Thomson J, et al. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med,1992, 326(6) :357.
9Felson DT,Zhang Y, Hannan MT, et al. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med, 1993,329(16) :1141.
10Grodstein F, Stampfer MJ,Goldhaber SZ, et al. Prospective study of exogenous hormones and risk of pulmonary embolism in women.Lancet, 1996,348 (9033) :983.
